Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.

[1]  A. Kassam,et al.  Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. , 2006, Journal of neurosurgery.

[2]  M. Bindu,et al.  Hypoparathyroidism: A rare treatable cause of epilepsy – report of two cases , 2006, European journal of neurology.

[3]  H. Steiger,et al.  Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. , 2006, Neurosurgery.

[4]  G. Rinkel,et al.  Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. , 2006 .

[5]  S. Mayer,et al.  Medical complications after subarachnoid hemorrhage: new strategies for prevention and management , 2006, Current opinion in critical care.

[6]  W. Poon,et al.  Intravenous Magnesium Sulfate After Aneurysmal Subarachnoid Hemorrhage: A Prospective Randomized Pilot Study , 2006, Journal of neurosurgical anesthesiology.

[7]  D. Prevedello,et al.  Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity. , 2006, Surgical neurology.

[8]  A. V. van Norden,et al.  Dose evaluation for long‐term magnesium treatment in aneurysmal subarachnoid haemorrhage , 2005, Journal of clinical pharmacy and therapeutics.

[9]  W. M. van den Bergh.  Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial , 2005, Stroke.

[10]  H Hunt Batjer,et al.  Prediction of Cerebral Vasospasm in Patients Presenting with Aneurysmal Subarachnoid Hemorrhage: A Review , 2005, Neurosurgery.

[11]  M. Schwartz,et al.  Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine. , 2004, American journal of obstetrics and gynecology.

[12]  S. Mazza,et al.  Tonic-Clonic Seizures in a Patient with Primary Hypoparathyroidism: A Case Report , 2004, Clinical EEG and neuroscience.

[13]  C. Ariyan,et al.  Assessment and management of patients with abnormal calcium , 2004, Critical care medicine.

[14]  S C Lewis,et al.  How to spot bias and other potential problems in randomised controlled trials , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  N. Kitchen,et al.  Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage , 2003, The Lancet Neurology.

[16]  A. Algra,et al.  Hypomagnesemia after aneurysmal subarachnoid hemorrhage. , 2003 .

[17]  G. Rinkel,et al.  Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment , 2003, Acta Neurochirurgica.

[18]  M. Morgan,et al.  Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage , 2002, Journal of Clinical Neuroscience.

[19]  N. Dorsch.  Therapeutic approaches to vasospasm in subarachnoid hemorrhage , 2002, Current opinion in critical care.

[20]  M. Mlynarek,et al.  Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. , 2002, Journal of neurosurgery.

[21]  R. Boet,et al.  Magnesium Sulfate in the Management of Patients with Fisher Grade 3 Subarachnoid Hemorrhage: A Pilot Study , 2000, Neurosurgery.

[22]  H. Mayan,et al.  Symptomatic hypocalcaemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy--possible involvement of the calcium-sensing receptor. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  E. Eisenbud,et al.  Hypocalcemia after therapeutic use of magnesium sulfate. , 1976, Archives of internal medicine.

[24]  N. Krayenbühl,et al.  Cerebral vasospasm: results of a structured multimodal treatment. , 2005, Acta neurochirurgica. Supplement.

[25]  A. Qureshi,et al.  The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage , 2005, Neurocritical care.